rs121913355
|
|
Carcinoma of lung
|
G |
0.700 |
CausalMutation
|
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913355
|
|
Carcinoma of lung
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Missense mutations of the BRAF gene in human lung adenocarcinoma.
|
12460919 |
2002 |
rs121913355
|
|
Neoplasms
|
G |
0.730 |
GeneticVariation
|
CLINVAR |
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
|
15035987 |
2004 |
rs121913355
|
|
Cardio-facio-cutaneous syndrome
|
T |
0.800 |
CausalMutation
|
CLINVAR |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
rs121913355
|
|
Cardio-facio-cutaneous syndrome
|
T |
0.800 |
CausalMutation
|
CLINVAR |
Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
|
18042262 |
2008 |
rs121913355
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
|
18186519 |
2008 |
rs121913355
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
|
18186519 |
2008 |
rs121913355
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
|
18186519 |
2008 |
rs121913355
|
|
melanoma
|
T |
0.710 |
GeneticVariation
|
CLINVAR |
These G469E- and D594G-mutated melanomas were found to exhibit constitutive levels of phospho-extracellular signal-regulated kinase (pERK) and low levels of phospho-mitogen-activated protein kinase/ERK kinase (pMEK) and were resistant to MEK inhibition.
|
18794803 |
2009 |
rs121913355
|
|
Carcinoma of lung
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Genetic predictors of MEK dependence in non-small cell lung cancer.
|
19010912 |
2008 |
rs121913355
|
|
Carcinoma of lung
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
|
19238210 |
2009 |
rs121913355
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913355
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913355
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913355
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.
|
20350999 |
2010 |
rs121913355
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.
|
20350999 |
2010 |
rs121913355
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.
|
20350999 |
2010 |
rs121913355
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
|
21129611 |
2010 |
rs121913355
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
|
21129611 |
2010 |
rs121913355
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
|
21129611 |
2010 |
rs121913355
|
|
Carcinoma of lung
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.
|
21483012 |
2011 |
rs121913355
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
The road to resistance: EGFR mutation and cetuximab.
|
22310681 |
2012 |
rs121913355
|
|
Colorectal Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
The road to resistance: EGFR mutation and cetuximab.
|
22310681 |
2012 |
rs121913355
|
|
Colorectal Neoplasms
|
T |
0.700 |
CausalMutation
|
CLINVAR |
The road to resistance: EGFR mutation and cetuximab.
|
22310681 |
2012 |
rs121913355
|
|
Carcinoma of lung
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib.
|
22649091 |
2012 |